. . . . . . . "[In patients with HCV and HIV-1, more adverse events occurred with TVR versus placebo plus PEG-IFN-?2a-ribavirin; these were similar in nature and severity to those in patients with HCV treated with TVR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:13:36+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .